두개내 동맥류 시장 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Intracranial Aneurysm Market was valued at USD 1.6 billion in 2025 and is estimated to grow at a CAGR of 9.1% to reach USD 4 billion by 2035.

Market expansion is driven by rapid progress in minimally invasive neurovascular technologies, a growing clinical preference for endovascular therapies over open surgical approaches, and the rising incidence of intracranial aneurysms worldwide. An intracranial aneurysm is defined as a localized weakening and outward bulging of a cerebral blood vessel caused by arterial wall degeneration. Over time, this condition can worsen and carries a serious risk of rupture, which may result in life-threatening intracranial bleeding. These aneurysms are most identified near arterial junctions within the brain. Advancements in device engineering and procedural techniques have significantly improved treatment precision, reduced intervention time, and lowered complication rates. As healthcare systems increasingly prioritize less invasive treatment pathways, adoption of modern neurointerventional procedures continues to rise globally. Ongoing research initiatives and sustained innovation by leading manufacturers are improving patient outcomes and supporting consistent market growth across developed and emerging healthcare systems.

The endovascular coiling segment held a 66.7% share in 2025 owing to its minimally invasive approach and strong clinical performance. This technique is widely favored for both ruptured and unruptured aneurysms, particularly among elderly patients and individuals with elevated surgical risk. Shorter recovery timelines and reduced procedural burden continue to support its role as a primary treatment option, with procedure volumes rising as hospitals expand minimally invasive care models.

The hospitals segment accounted for a 65% share in 2025 and is expected to generate USD 2.5 billion through 2035. High patient admissions related to acute neurovascular events and aneurysm complications are driving demand for hospital-based treatment. Hospitals provide integrated access to specialized clinicians, advanced imaging, and intensive care, enabling rapid and coordinated management of complex aneurysm cases.

North America Intracranial Aneurysm Market held a 41.7% share in 2025. The region experiences a high disease burden linked to aging populations and lifestyle-related risk factors. Increased screening rates and early diagnosis are supporting treatment demand. Well-established neurovascular infrastructure and advanced procedural capabilities further strengthen regional market leadership.

Key companies operating in the Global Intracranial Aneurysm Market include Medtronic, Stryker, TERUMO, Johnson & Johnson, Penumbra, B. BRAUN, Balt Group, MicroPort, INTEGRA, Shape Memory Medical, phenox, Wallaby Medical, ZYLOX TONBRIDGE, MIZUHO, and Peter LAZIC. Companies in the Global Intracranial Aneurysm Market are reinforcing their market position through sustained investment in research, technology refinement, and clinical validation. Manufacturers are focused on developing safer, more effective minimally invasive solutions that improve long-term patient outcomes. Strategic partnerships with hospitals and research institutions help accelerate product adoption and clinical acceptance. Geographic expansion into underserved regions supports volume growth, while regulatory approvals strengthen global reach. Many players are also investing in physician training programs and procedural education to increase familiarity with advanced treatment options.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Treatment type trends
  • 2.2.3 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of hypertension and lifestyle-related diseases
    • 3.2.1.2 Growth in neurointerventional procedures and trained specialists
    • 3.2.1.3 Technological advances in endovascular devices
    • 3.2.1.4 Increasing awareness about intracranial aneurysms
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of devices and procedures
    • 3.2.2.2 Risk of peri- and post-procedural complications and morbidity
  • 3.2.3 Market opportunities
    • 3.2.3.1 Expansion into emerging markets with growing healthcare infrastructure
    • 3.2.3.2 Surging need for personalized implants, 3D-printed devices, and patient-specific planning
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Reimbursement scenario
• 3.7 Consumer insights
• 3.8 Future market trends
• 3.9 Value chain analysis
• 3.10 Porter's analysis
• 3.11 PESTEL analysis
• 3.12 Gap analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Treatment Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Endovascular coiling
• 5.3 Surgical clipping
• 5.4 Flow diverters
• 5.5 Other treatment types

Chapter 6 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Ambulatory surgical centers
• 6.4 Other end use

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 B. BRAUN
• 8.2 Balt Group
• 8.3 INTEGRA
• 8.4 Johnson & Johnson
• 8.5 Medtronic
• 8.6 MicroPort
• 8.7 MIZUHO
• 8.8 Penumbra
• 8.9 Peter LAZIC
• 8.10 phenox
• 8.11 Shape Memory Medical
• 8.12 Stryker
• 8.13 TERUMO
• 8.14 Wallaby Medical
• 8.15 ZYLOX TONBRIDGE